Profile
Full Name
Intensity Therapeutics, Inc.Ticker Symbol
INTSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 30, 2023Indexes
Not includedEmployees
5Key Details
Price
$1.91(+2.14%)
Market cap
$29.00M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.17(+15.22% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Intensity Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jan 13, 25 Alliance Global Partners
BuyNov 21, 24 HC Wainwright & Co.
BuyOct 31, 24 HC Wainwright & Co.
BuyJul 11, 24 Benchmark
Speculative BuyMay 16, 24 Benchmark
Speculative BuyMar 21, 24 Benchmark
Speculative BuyNov 14, 23 Benchmark
Speculative BuyAug 24, 23 Benchmark
Speculative BuyJul 18, 23 Benchmark
Speculative BuyInstitutional Ownership
- What is the ticker symbol for Intensity Therapeutics?
- Does Intensity Therapeutics pay dividends?
- What sector is Intensity Therapeutics in?
- What industry is Intensity Therapeutics in?
- What country is Intensity Therapeutics based in?
- When did Intensity Therapeutics go public?
- Is Intensity Therapeutics in the S&P 500?
- Is Intensity Therapeutics in the NASDAQ 100?
- Is Intensity Therapeutics in the Dow Jones?
- When was Intensity Therapeutics's last earnings report?
- When does Intensity Therapeutics report earnings?
- Should I buy Intensity Therapeutics stock now?
What is the ticker symbol for Intensity Therapeutics?
The ticker symbol for Intensity Therapeutics is NASDAQ:INTS
Does Intensity Therapeutics pay dividends?
No, Intensity Therapeutics does not pay dividends
What sector is Intensity Therapeutics in?
Intensity Therapeutics is in the Healthcare sector
What industry is Intensity Therapeutics in?
Intensity Therapeutics is in the Biotechnology industry
What country is Intensity Therapeutics based in?
Intensity Therapeutics is headquartered in United States
When did Intensity Therapeutics go public?
Intensity Therapeutics's initial public offering (IPO) was on June 30, 2023
Is Intensity Therapeutics in the S&P 500?
No, Intensity Therapeutics is not included in the S&P 500 index
Is Intensity Therapeutics in the NASDAQ 100?
No, Intensity Therapeutics is not included in the NASDAQ 100 index
Is Intensity Therapeutics in the Dow Jones?
No, Intensity Therapeutics is not included in the Dow Jones index
When was Intensity Therapeutics's last earnings report?
Intensity Therapeutics's most recent earnings report was on Mar 13, 2025
When does Intensity Therapeutics report earnings?
The next expected earnings date for Intensity Therapeutics is May 9, 2025
Should I buy Intensity Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions